Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study.
Bergin SP, Chemaly RF, Dadwal SS, Hill JA, Lee YJ, Haidar G, Luk A, Drelick A, Chin-Hong PV, Benamu E, Khawaja F, Nanayakkara D, Papanicolaou GA, Small CB, Fung M, Barron MA, Davis T, McClain MT, Maziarz EK, Madut DB, Bedoya AD, Gilstrap DL, Todd JL, Barkauskas CE, Bigelow R, Leimberger JD, Tsalik EL, Wolf O, Mughar M, Hollemon D, Duttagupta R, Lupu DS, Bercovici S, Perkins BA, Blauwkamp TA, Fowler VG Jr, Holland TL. Bergin SP, et al. Among authors: todd jl. Clin Infect Dis. 2024 Mar 20;78(3):775-784. doi: 10.1093/cid/ciad599. Clin Infect Dis. 2024. PMID: 37815489 Free PMC article.
Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing Among Immunocompromised Patients With Pneumonia.
Madut DB, Chemaly RF, Dadwal SS, Hill JA, Lee YJ, Haidar G, Luk A, Drelick A, Chin-Hong PV, Benamu E, Khawaja F, Nanayakkara D, Papanicolaou GA, Small CB, Fung M, Barron M, Davis T, McClain MT, Maziarz EK, Bedoya AD, Gilstrap DL, Todd JL, Barkauskas CE, Heldman MR, Bigelow R, Leimberger JD, Tsalik EL, Wolf O, Mughar M, Lau C, Noll N, Hollemon D, Duttagupta R, Lupu DS, Bercovici S, Perkins BA, Blauwkamp TA, Fowler VG Jr, Holland TL, Bergin SP. Madut DB, et al. Among authors: todd jl. Open Forum Infect Dis. 2024 Jul 22;11(8):ofae425. doi: 10.1093/ofid/ofae425. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39091643 Free PMC article.
International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation.
Martinu T, Koutsokera A, Benden C, Cantu E, Chambers D, Cypel M, Edelman J, Emtiazjoo A, Fisher AJ, Greenland JR, Hayes D Jr, Hwang D, Keller BC, Lease ED, Perch M, Sato M, Todd JL, Verleden S, von der Thüsen J, Weigt SS, Keshavjee S; bronchoalveolar lavage standardization workgroup. Martinu T, et al. Among authors: todd jl. J Heart Lung Transplant. 2020 Nov;39(11):1171-1190. doi: 10.1016/j.healun.2020.07.006. Epub 2020 Jul 15. J Heart Lung Transplant. 2020. PMID: 32773322 Free PMC article.
Prognosis and Risks for Probable Chronic Lung Allograft Dysfunction: A Prospective Multicenter Study.
Todd JL, Weigt SS, Neely ML, Grau-Sepulveda MV, Mason K, Sever ML, Kesler K, Kirchner J, Frankel CW, Martinu T, Shino MY, Jackson AM, Pavlisko EN, Williams N, Robien MA, Singer LG, Budev M, Tsuang W, Shah PD, Reynolds JM, Snyder LD, Belperio JA, Palmer SM. Todd JL, et al. Am J Respir Crit Care Med. 2024 Oct 29. doi: 10.1164/rccm.202403-0568OC. Online ahead of print. Am J Respir Crit Care Med. 2024. PMID: 39470452
Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction.
Todd JL, Weber JM, Kelly FL, Nagler A, McArthur P, Eason L, Rim JG, Frankel CW, Belperio JA, Budev M, Martinu T, Patel K, Reynolds JM, Shah PD, Singer LG, Snyder LD, Tsuang W, Weigt SS, Neely ML, Palmer SM. Todd JL, et al. J Heart Lung Transplant. 2024 Oct 22:S1053-2498(24)01900-4. doi: 10.1016/j.healun.2024.10.014. Online ahead of print. J Heart Lung Transplant. 2024. PMID: 39448000
Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: Data from the IPF-PRO Registry.
Amubieya O, Todd JL, Neely ML, Kaner RJ, Lasky JA, Namen A, Hesslinger C, Palmer SM, Weigt SS, Belperio JA. Amubieya O, et al. Among authors: todd jl. PLoS One. 2024 Oct 17;19(10):e0312044. doi: 10.1371/journal.pone.0312044. eCollection 2024. PLoS One. 2024. PMID: 39418259 Free PMC article.
Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic Therapy.
Söllner JF, Bentink S, Hesslinger C, Leonard TB, Neely ML, Patel NM, Schlange T, Todd JL, Vinisko R, Salisbury ML; IPF-PRO Registry investigators. Söllner JF, et al. Among authors: todd jl. Lung. 2024 Oct;202(5):595-599. doi: 10.1007/s00408-024-00742-x. Epub 2024 Sep 6. Lung. 2024. PMID: 39242435 Free PMC article.
Alterations in circulating measures of Th2 immune responses pre-lung transplant associates with reduced primary graft dysfunction.
Schaenman JM, Weigt SS, Pan M, Lee JJ, Zhou X, Elashoff D, Shino MY, Reynolds JM, Budev M, Shah P, Singer LG, Todd JL, Snyder LD, Palmer S, Belperio J. Schaenman JM, et al. Among authors: todd jl. J Heart Lung Transplant. 2024 Nov;43(11):1869-1872. doi: 10.1016/j.healun.2024.07.011. Epub 2024 Jul 17. J Heart Lung Transplant. 2024. PMID: 39029637 Free article.
105 results